or
forgot password
  • cancer clinical trials in charlottesville, VA

  • Modafinil in Treating Fatigue in Patients With Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Cognitive/Functional Effects, Depression, Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Breast Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    University of Virginia
    Charlottesville, Virginia 22908
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Martha Jefferson Hospital

    Trial Locations
    Martha Jefferson Hospital
    University of Virginia
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Colorectal Cancer
    Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Cancer of the Cervix
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    University of Virginia
    Charlottesville, Virginia 22908
    Melanoma
    Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Kidney Cancer
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    University of Virginia
    Charlottesville, Virginia 22908
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Martha Jefferson Hospital

    Trial Locations
    Martha Jefferson Hospital
    University of Virginia
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    University of Virginia
    Charlottesville, Virginia 22908
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    University of Virginia
    Charlottesville, Virginia 22908
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    University of Virginia
    Charlottesville, Virginia 22908
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    A Randomized Trial of Unruptured Brain AVMs
    University of Virginia School of Medicine, Department of Neurosurgery, P.O. Box 800212
    Charlottesville, Virginia 22908
    Unruptured Brain Arteriovenous Malformation
    Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
    University of Virginia
    Charlottesville, Virginia 22908
    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    University of Virginia
    Charlottesville, Virginia 22908
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
    University of Virginia
    Charlottesville, Virginia 22908
    Glioblastoma Multiforme, Gliosarcoma
    Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Ovarian Cancer
    Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
    Celldex Investigational Site
    Charlottesville, Virginia 22908
    Malignant Glioma
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Lung Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Neuroblastoma
    Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors, Neurofibromatosis Type 1, Neurofibromatosis Type 2, Precancerous Condition
    CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
    University of Virgina
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors, Recurrent Glioblastoma Multiforme
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
    University of Virginia Health Science Center
    Charlottesville, Virginia 22908
    CNS Cancer, Meningioma, Intracranial Hemangiopericytoma, Hemangioblastoma, Neurofibromatosis
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    University of Virginia
    Charlottesville, Virginia 22908
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Acupuncture for Polycystic Ovarian Syndrome
    University of Virginia
    Charlottesville, Virginia 22908
    Polycystic Ovary Syndrome
    A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
    University of Virginia
    Charlottesville, Virginia 22908
    Malignant Glioma, Glioblastoma Multiforme, GBM, Astrocytoma, Oligodendroglioma
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    University of Virginia
    Charlottesville, Virginia 22908
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pharmacogenetics of Metformin Action in PCOS
    University Of Virginia General Clinical Research Center
    Charlottesville, Virginia 22908
    Polycystic Ovary Syndrome
    Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Glioblastoma Multiforme
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    FTY720 in Patients With Primary Progressive Multiple Sclerosis
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Primary Progressive Multiple Sclerosis
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Martha Jefferson Hospital

    Trial Locations
    Martha Jefferson Hospital
    University of Virginia
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Tumor, Ovarian Cancer
    LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
    University of Virginia, Department of Neurology
    Charlottesville, Virginia 22908
    Malignant Glioma
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Lung Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer